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ABBREVIATIONS LIST 28 
BCT: behavior change technique 29 
COPD: chronic obstructive pulmonary disease 30 
CF: cystic fibrosis 31 
IQR: interquartile range 32 
MRC: medical research council 33 
mRCT: metaregister of controlled trials 34 
OSA: obstructive sleep apnea 35 
Psych: psychologist 36 
RT/PT: respiratory therapist/physical therapist 37 
SD: standard deviation 38 
SDM: shared decision making 39 
SEM: standard error of the mean 40 
TIDiER: template for intervention description and replication 41 
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ABSTRACT  46 
Background: We sought to describe the theory used to design treatment adherence interventions, the 47 
content delivered, and the mode of delivery of these interventions in chronic respiratory disease. 48 
Methods: We included randomized controlled trials of adherence interventions (compared to another 49 
intervention or control) in adults with chronic respiratory disease (8 databases searched; inception until 50 
March 2015). Two reviewers screened and extracted data: post-intervention adherence (measured 51 
objectively); behavior change theory, content (grouped into psychological, education and self-52 
management/supportive, telemonitoring, shared decision-making); and delivery. “Effective” studies 53 
were those with p<0.05 for adherence rate between groups. We conducted a narrative synthesis and 54 
assessed risk of bias. 55 
Results: 12,488 articles screened; 46 included studies (n=42,91% in OSA or asthma) testing 58 56 
interventions (n=27, 47% were effective). Nineteen (33%) interventions (15 studies) used 12 different 57 
behavior change theories. Use of theory (n=11,41%) was more common amongst effective interventions. 58 
Interventions were mainly educational, self-management or supportive interventions (n=27,47%). They 59 
were commonly delivered by a doctor (n=20,23%), in face-to-face (n=48,70%), one-to-one (n=45,78%) 60 
outpatient settings (n=46,79%) across 2-5 sessions (n=26,45%) for 1-3 months (n=26,45%). Doctors 61 
delivered a lower proportion (n=7,18% vs n=13,28%) and pharmacists (n=6,15% vs n=1,2%) a higher 62 
proportion of effective than ineffective interventions. Risk of bias was high in >1 domain (n=43, 93%) in 63 
most studies.  64 
Conclusions: Behavior change theory was more commonly used to design effective interventions. Few 65 
adherence interventions have been developed using theory, representing a gap between intervention 66 
design recommendations and research practice.  67 
 68 
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INTRODUCTION 70 
Adherence, the extent to which patients’ behaviors follow a recommended treatment path1, is widely 71 
reported as being sub-optimal.2 Chronic respiratory disease is no different – it is reported that between 72 
30-50% of patients take treatment as prescribed.3–5 This lack of adherence is not inconsequential; low 73 
adherence is associated with treatment failure and poor health outcomes.5–7  74 
Many researchers have attempted to change adherence to prescribed treatments in chronic respiratory 75 
disease by developing behavior change interventions.8–11 Medical Research Council (MRC) guidance 76 
states that these interventions should be developed systematically and involve the use of behavior 77 
change theories.12 Yet studies of other complex interventions demonstrate that behavior change 78 
theories are rarely used.12,13 The TIDieR reporting guidelines also recommend that the behavior change 79 
theory used to design the intervention should be reported alongside a detailed description of what was 80 
actually delivered (content) and how this was delivered (who provided the intervention, what was the 81 
mode of delivery, where was it delivered, in what frequency and over what duration).14  82 
Systematic reviews of interventions to change adherence behavior in chronic respiratory disease have 83 
synthesised the evidence for the effectiveness of these interventions.2,15 But they have not focused 84 
specifically on synthesising data on whether behavior change theories were used in their development, 85 
nor have they explored the content or the delivery of these interventions. These data are needed to 86 
inform the development of new interventions and to allow implementation of effective interventions 87 
into clinical practice. This systematic review describes the behavior change theories used to develop 88 
adherence interventions (compared to another intervention or usual care) in adults with chronic 89 
respiratory disease, the content that was delivered, along with who provided it, its mode of delivery, 90 
where it was delivered, in what frequency and over what duration. 91 
MATERIALS AND METHODS 92 
Inclusion and exclusion criteria for studies 93 
We included randomized controlled trials (RCTs) of adults ≥ 18 years old, with a clinical diagnosis of 94 
chronic respiratory disease (asthma, bronchiectasis, chronic obstructive pulmonary disease [COPD], 95 
allergic bronchopulmonary aspergillosis, interstitial lung disease, obstructive sleep apnea [OSA]16 or 96 
cystic fibrosis [CF]) who received an adherence to treatment (any treatment with the exception of 97 
exercise) intervention compared to another intervention or usual care, where adherence was objectively 98 
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measured (e.g. electronic monitoring, pill counts or medication possession data). Only objective 99 
measures of adherence were included because subjective adherence measurements (e.g. self-report 100 
questionnaire) are known to over-estimate adherence.17 Studies measuring adherence to exercise or 101 
those available in abstract form only, were excluded. No attempt was made to identify unpublished 102 
studies. This review was not registered on PROSPERO but the protocol can be obtained from the authors. 103 
No ethical approval was required for this study.  104 
Search strategy 105 
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), Medline, EMBASE, CINAHL, 106 
International Pharmaceutical Abstracts, PsycINFO, Sociological abstracts and PEDro from inception until 107 
March 2015 using the search strategy outlined in the online supplement. Language was restricted to 108 
English. We searched the metaRegister of controlled trials (mRCT), ClinicalTrials.gov and the WHO trials 109 
portal using the keywords ‘adherence’, ‘compliance’ and ‘concordance.’  110 
Study selection 111 
Pairs of reviewers screened titles, abstracts and subsequent full texts (AMcC, CR, NY, CM, BON, JB, CH 112 
plus three research assistants. All screeners received written instructions on screening from AMcC to 113 
ensure consistency in approach (available on request from AMcC). Conflicts were resolved between 114 
pairs and disagreements were resolved by a third reviewer (AMcC or CH).   115 
Data extraction 116 
Pairs of reviewers (AMcC and CR, NY and CM) extracted data on study design, participants and the 117 
number of interventions tested (e.g. a three-arm study where two interventions were tested against 118 
usual care would have two intervention arms). For each intervention, we extracted (from the abstract, 119 
introduction, methods, results or discussion sections) the name of any behavior change theory used, the 120 
content delivered, who provided the intervention, the mode of delivery, where it was delivered, in what 121 
frequency and over what duration (items 2-8 of the TIDieR checklist14). Reviewers also extracted mean 122 
(±SD, 95% CI or SEM) or median (IQR or range) and p values for objective adherence to treatment in 123 
intervention and control groups at the end of study follow-up. If no other measures were reported, 124 
mean change, mean difference (±SD) or the number of participants (%) categorized as adherent were 125 
extracted. Pairs of reviewers (AMcC and CR, NY and CM) assessed each study’s risk of bias (as high, 126 
unclear or low, using the Cochrane Collaboration’s tool for assessing risk of bias) across six domains: 127 
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random sequence generation, allocation concealment, blinding of participants and personnel, blinding 128 
of outcome assessment, incomplete outcome data, and selective reporting.  129 
Synthesis of results and summary measures 130 
Included studies could not be meta-analysed due to heterogeneity in the outcome measures used and 131 
the interventions tested.  Without meta-analysis, we could not determine the statistical importance of 132 
theory, content and delivery using meta-regression. Consequently, we narratively described the 133 
behavior change theories used in intervention development, and provided descriptive statistics of what 134 
content was delivered, who provided the intervention, what the mode of delivery was, where it was 135 
delivered, in what frequency and over what duration. Classification of the content of complex 136 
interventions is difficult, due to overlap in content between different interventions. However, we 137 
grouped interventions by content (psychological; education and supportive or self-management; 138 
telemonitoring; and shared decision-making interventions) by consensus within the research team. 139 
More than one clinician may have delivered a single intervention; each profession is counted separately. 140 
We categorized interventions into “effective” (p<0.05 for adherence rate between groups), or 141 
“ineffective” (p>0.05) by whether they were associated with statistically significant improvements in 142 
objective adherence.  143 
RESULTS 144 
Summary of studies 145 
Screening resulted in the inclusion of 46 studies (Figure 1) testing 58 interventions in 12,415 participants 146 
(median 100 per study, range 12-6431) (e-Table 1-3). Most studies included patients with OSA or asthma 147 
(Figure 1). Twenty-seven interventions (47%) were shown to be effective (e-Table 4-6).  148 
Behavior change theory used in intervention development 149 
Most (n=39, 67%) interventions were not based on behavior change theory (Figure 2). Nineteen 150 
interventions (33%) (from 15 studies) were designed using 12 different behavior change theories (Table 151 
1). A higher proportion of effective interventions (n=11, 41%) used behavior change theory to design 152 
their intervention than ineffective interventions (n=8, 26%) (Figure 3).  153 
Content  154 
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Most (n=27, 47%) interventions delivered educational, self-management or supportive content (Figure 155 
2). Educational, self-management or supportive content was more common for ineffective interventions 156 
(n=17, 55%) than effective interventions (n=10, 37%) (Figure 3). Detailed descriptions of intervention 157 
content are provided in eTable 1-3. 158 
Delivery 159 
The majority of interventions were delivered by doctors or nurses, on a face-to-face, one-to-one, out-160 
patient basis across two to five visits, at various frequencies over the course of one to three months 161 
(Figure 2). Doctors delivered a lower proportion of effective interventions (n=7, 18%) compared to 162 
ineffective (n=13, 28%). Pharmacists delivered a higher proportion of effective (n=6, 15%) compared to 163 
ineffective interventions (n=1, 2%). No other differences could be identified in who provided the 164 
intervention, the mode of delivery, where was it delivered, in what frequency and over what duration. 165 
Risk of Bias 166 
Three studies had a low risk of bias. We rated the remaining studies as having an unclear or high risk of 167 
bias in one or more domains (high risk in ≥1 domains, n=28; unclear risk in ≥1 domains, n=43) (Figure 4, 168 
e-Figure 1).   169 
 170 
DISCUSSION 171 
Most adherence interventions did not use behavior change theories in their development. Of those that 172 
did, they used 12 different behavior change theories. Use of behavior change theory was more common 173 
amongst effective interventions. Most adherence interventions used educational and self-management 174 
or supportive interventions delivered on a face-to-face, one-to-one out-patient basis (up to five visits, 175 
one to three months). Interventions with educational, self-management or supportive content 176 
constituted over half of ineffective interventions. Doctors delivered a lower proportion of the effective 177 
interventions, and pharmacists a higher proportion of effective interventions (compared to ineffective 178 
interventions). 179 
One third of studies reported using behavior change theories in their development and more studies in 180 
the effective interventions group used behavior change theory, adding weight to the recommendations 181 
to use behavior change theory to design interventions.12 Our findings are limited by the small number of 182 
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studies that reported using theory, and the extent to which these theories were used to inform the 183 
intervention is not known. Given the poor reporting noted in behavior change interventions, it is also 184 
possible that more studies used theory but did not report it.16 Only self-efficacy theory and social 185 
cognitive theory were used in more than one study. This is not surprising, given the range of behavior 186 
change theories that exist. At the time that many of these interventions were designed, there was no 187 
clear cut way of defining which theories to use and how to use them. Michie and colleagues have 188 
attempted to remedy this issue by creating the Theoretical Domains Framework, in which they have 189 
combined 128 explanatory constructs from 33 behavior change theories into a single framework of 14 190 
domains.13,20 191 
Interventions using education, self-management or supportive approaches were more common 192 
amongst ineffective interventions. The categories which were used to group content were broad and 193 
the educational content varied greatly between studies, from group education21 to patient advocates.22 194 
Defining intervention content and grouping similar interventions is a common challenge when reviewing 195 
behavior change interventions and is a limitation of this review. This is due to the variety of 196 
interventions used and is, in part, due to poor reporting of the exact content of interventions.23 The 197 
Behavior Change Technique (BCT) Taxonomy (published after this review commenced) attempts to 198 
overcome this issue by defining the individual components of behavior change interventions in a 199 
reproducible way by providing definitions and examples.24 It has been used in other systematic reviews 200 
to extract the components of existing interventions.25 The main challenge with using this approach is 201 
that the original intervention content was not designed to be defined by behavior change techniques 202 
and is so poorly reported that is makes it nearly impossible to use this approach.25 Future adherence 203 
intervention studies should describe their interventions using the BCT Taxonomy24 and report them 204 
using reporting checklists such as TIDiER and CONSORT.14,26 Many studies in this review reported study 205 
designs and outcomes poorly; the use of these checklists would also address these issues. An adherence 206 
intervention for bronchiectasis has been developed using this approach, and is currently under further 207 
development prior to feasibility and pilot testing.27  208 
Findings from this review demonstrated that a higher proportion of effective interventions were 209 
delivered by pharmacists, and a lower proportion by doctors. It is possible that pharmacists have more 210 
time, and receive more training on how to monitor and change adherence behaviour, or that those 211 
interventions led by pharmacists contained components that specifically targeted the underlying 212 
barriers and facilitators to adherence. No other differences in delivery were identified. It is likely that 213 
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there is no ‘one-size fits all’ approach to intervention delivery and will depend on the healthcare context 214 
in which the intervention is likely to be effective.28  As an example, in cystic fibrosis, a group-based 215 
primary care intervention delivered by a general practitioner and/or practice nurse is unlikely to be 216 
effective given that most care is delivered by specialists in secondary care and patients are treated in 217 
isolation of one another. In contrast, for COPD, this approach might be appropriate given that they 218 
already receive annual reviews and have contact with their general practitioner and practice nurse (if in 219 
the United Kingdom). Thus, researchers should involve stakeholders in intervention design to identify 220 
the most appropriate delivery method for their patient population and healthcare context.29 221 
Most studies in this review included those with OSA or asthma, making the findings more generalizable 222 
to those populations. Clear gaps exist for patients with COPD, bronchiectasis and CF, who are known to 223 
have low adherence.5–7 Research is beginning to focus on developing adherence interventions for these 224 
groups27,30,31 and this is an area for further development.  225 
Our data show that the education, self-management and supportive approaches that may be commonly 226 
used in clinical practice may not always be effective at improving adherence, and that using theory-227 
based interventions may be more useful for clinicians to implement with patients.  228 
Strengths of this review include: its broad scope, incorporating all adherence interventions across any 229 
chronic respiratory disease or clinical setting, and the inclusion of studies reporting objective measures 230 
of adherence. Comparisons between the use behavior change theory, content and delivery were 231 
descriptive and based on small numbers of studies and should be interpreted with caution. The 232 
heterogeneity of included interventions made categorization of intervention content problematic. We 233 
only extracted data on adherence from final study visits, meaning any interim effects have not been 234 
captured. Our search was restricted to English language and we did not contact authors to identify 235 
unpublished studies, meaning the results presented could be affected by publication bias. We did not 236 
extract any data on recruitment rates for individual studies which may affect the generalisability of the 237 
findings presented.  238 
Conclusion 239 
Behavior change theory use was more common amongst effective interventions, providing evidence 240 
that this in an important consideration for future adherence interventions. Few adherence interventions 241 
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have been developed using theory, representing a gap between medical research guidance and research 242 
practice.  243 
  244 
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FIGURE LEGENDS 
Figure 1. PRISMA chart of review process 
Figure 2.  Summary of behavior change theory, content, and delivery of all interventions 
SDM: shared decision making 
RT/PT: respiratory therapist/physiotherapist 
Psych: psychologist 
Unknown: not reported in the manuscript 
Numbers in bars denote percentage with each characteristic 
 
Figure 3.  Summary of behavior change theory, content, and delivery of effective and ineffective 
interventions 
SDM: shared decision making 
RT/PT: respiratory therapist/physiotherapist 
Psych: psychologist 
Unknown: not reported in the manuscript 
Numbers in bars denote percentage with each characteristic 
 
Figure 4. Summary of risk of bias of included studies 
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Table 1. Psychological theories used in the design of adherence interventions for OSA, asthma and 
COPD 
Psychological theories used 
Compliance therapy model10  
Decisional balance32  
Health Belief Model33  
Horne and Weinman’s Benefit-risk model34  
Patient navigator model 22 
Prospect theory 35 
Protection motivation theory36  
Self-efficacy theory32,37  
Social cognitive theory35,38,19,39,40 
Transtheoretical model38  
Triandis theory of behavior41  
“Theory-based” but specific theory not reported42,43 
